11 Questions 26 Answers 0 Followers
Questions related from Eduard Fidler
Hi All, I am working on conjugating mAbs to the surface of PLGA-PEG-MAL nanoparticles. Free thiols are added to the mAbs using Traut's reagent, which will then be added to the NP suspension. I am...
03 March 2016 2,602 8 View
Hi All, I want to reduce coupled Anti-EGFR mAbs for use in active-targeted nano-constructs. I want to use TCEP*HCl as my reducer but know that it causes (and actually needs) an acidic pH when used...
03 March 2016 4,465 11 View
Hi All, I am considering raising the concentration of my PBS solution to buffer against a pH drop during a mAb reaction step. Would that increase have any effect of the structure or affinity of my...
03 March 2016 6,046 4 View
Hi All, I am working with mAbs that are being exposed to a low pH (around 3 at the lowest) and was just wondering if that might be enough to cause them to lose some activity or even denature....
03 March 2016 4,314 4 View
Hi All, I am seeing protocols suggest including EDTA with a reducing agent when reducing disulfide bonds responsible for antibody accumulation and was just wondering how the EDTA's chelating...
03 March 2016 671 4 View
Hi All, I am trying to use DLS to verify that I am successfully reducing disulfide bonds responsible for the accumulation of mAbs in solution, yielding single uncoupled antibodies. Has anybody...
03 March 2016 3,812 5 View
Hi All, I am wondering how using polymers of differing molecular weights would affect the formation/properties of nanoparticles and why these differences would come about. Thank you! EF
02 February 2016 9,939 7 View
Hi All, I am wondering why Nanoparticles with conjugated mABs on their surface as targeting agents are successfully taken up by cells at the receptor site through Receptor-Mediated Endocytosis but...
01 January 2016 1,641 4 View
Hi All, I am working on a conjugation of a peptide to PLGA-PEG-MAL nanoparticles. I am currently making nanoparticles with PEG strands having 20% MAL endcaps, 80% methoxy. In theory, raising the...
01 January 2016 5,603 8 View
Hi All, I am working with the Erbitux (Cetuximab) monoclonal antibody and intend to conjugate it to PLGA-PEG nanoparticles for targeting, using maleimide. I have Erbitux from BMS that is ready...
09 September 2015 3,308 7 View
Hello All, I am trying to release antibodies (C225/Cetuximab/Erbitux) that have been physisorbed to the surface of PLGA-PEG-MAL nanoparticles without causing them to denature irreversibly. I am...
07 July 2015 6,097 5 View